October 13, 2025

Breast, Lung, and Bladder Cancer Phase 3 Trials led by Dana-Farber Presented at ESMO Congress 2025

Dana-Farber Cancer Institute researchers are leading four studies with important new findings in breast cancer, lung cancer, and bladder cancer at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany.

Dana-Farber

October 08, 2025

Breast Cancer Research: Updates for 2025

Novel treatment protocols are demonstrating significant improvements in overall survival and progression-free survival for breast cancer patients while targeted therapies continue to expand treatment options

Baptist Health South Florida

October 07, 2025

Artificial Intelligence: Bringing Revolutionary Change to Breast Cancer Screening — and to Your Own Practice

Physicians grappling with uncertainty about artificial intelligence’s role in medicine need look no further than breast radiologist Kathy Schilling, M.D., FACR, for guidance

Baptist Health South Florida

October 03, 2025

Older Women With High-Risk Breast Cancer: Addition of Adjuvant Chemotherapy to Hormone Therapy

In a French-Belgian phase III trial (ASTER 70s) reported in The Lancet, Brain et al examined the survival benefit of adding adjuvant chemotherapy to hormone therapy in women aged ≥ 70 years with estro...

The ASCO Post

October 03, 2025

Advanced or Metastatic Breast Cancer: FDA Approves Imlunestrant for ER-Positive, HER2-Negative, ESR1-Mutated Disease

The FDA approved the estrogen receptor antagonist for adults with estrogen receptor (ER)-positive, HER2-negative, estrogen receptor 1 (ESR1)-mutated advanced or metastatic disease with progression aft...

The ASCO Post

October 02, 2025

Can Older Breast Cancer Patients Tolerate Immunotherapy Plus Chemotherapy?

Using a newer combination of immunotherapy and lower doses of chemotherapy, USC Norris Comprehensive Cancer Center experts treated a 79-year-old woman with triple-negative breast cancer.

Keck Medicine of USC

September 30, 2025

Baptist Health Cancer Care Appoints Breast Surgical Oncologist Anastasia Tousimis, M.D., to Multiple Leadership Roles

https://baptisthealth.net/doctors/anastasia-tousimis/4857103

Baptist Health South Florida

September 18, 2025

Leading Societies Update Clinical Guideline on Postmastectomy Radiation Therapy

ASCO, ASTRO, and SSO have issued an updated guideline on postmastectomy radiation therapy (PMRT) for physicians treating patients with breast cancer. The recommendations outline when PMRT is appropria...

The ASCO Post

January 01, 0001

Overview of the AVADO and RIBBON-1 Clinical Trials

The evolving debate around bevacizumab's role in metastatic breast cancer reflects the complexities of targeted therapies and regulatory oversight.

JADPRO